Dadun Dadun cabecera universidad cabecera biblioteca
   (New user)
Help  | Contact  |  Castellano English  
 

Dadun > Depósito Académico > CIMA (Centro de Investigación Médica Aplicada) > Área de Terapia génica y Hepatología > Inmunología experimental > DA - CIMA - Terapia génica y Hepatología - Inmunología experimental - Artículos de revista >

Induction of neutralizing antibodies against human immunodeficiency virus type 1 using synthetic peptide constructs containing an immunodominant T-helper cell determinant from vpr
Authors: Sarobe, P. (Pablo)
Lasarte, J.J. (Juan José)
Golvano, J.J. (José Javier)
Prieto, I. (Isidro)
Gullon, A. (Arturo)
Soto, M.J. (María José)
Labarga, P. (Pablo)
Prieto, J. (Jesús)
Borras-Cuesta, F. (Francisco)
Keywords: Gene Products, vpr/immunology
HIV Antibodies/biosynthesis
HIV-1/immunology
Immunodominant Epitopes/immunology
T-Lymphocytes, Helper-Inducer/immunology
Issue Date: 1994
Publisher: Raven Press
Publisher version: http://journals.lww.com/jaids/Abstract/1994/07000/Induction_of_Neutralizing_Antibodies_Against_Human.1.aspx
ISSN: 0894-9255
Citation: Sarobe P, Lasarte JJ, Golvano JJ, Prieto I, Gullon A, Soto MJ, et al. Induction of neutralizing antibodies against human immunodeficiency virus type 1 using synthetic peptide constructs containing an immunodominant T-helper cell determinant from vpr. J Acquir Immune Defic Syndr 1994 Jul;7(7):635-640.
Abstract
Identification of immunodominant T-helper-cell determinants after natural infection is an important step in the design of immunogens for potential use in vaccination. Using cells from human immunodeficiency virus type 1 (HIV-1)-infected individuals and a panel of peptides encompassing the sequence of the regulatory protein vpr from HIV-1, we identified the T-helper determinant QLLFIHFRIGCRHSR, which is active in 37.5% of these individuals. To gain insight on the efficacy of this peptide in helping induce neutralizing antibodies against a B-cell determinant (BD), we synthesized constructs containing B- and T-cell determinants and tested them in BALB/c mice, the highest responders to the T-cell determinant moiety among several strains tested. These immunogens induced antibodies against two chosen B-cell determinants from HIV-1IIIB gp160 (amino acids 310-322 from the V3 loop of gp120 and 736-751 from gp41) that were able to neutralize HIV-1 infection in vitro. The highest neutralization titer against HIV-1IIIB was obtained by immunization with the homopolymer of the construct containing the T-cell epitope from vpr and the B-cell epitope from the V3 loop. We believe that the immunodominant T-cell determinant from vpr is a promising epitope to consider in the design of future peptide vaccines.
Permanent link: http://hdl.handle.net/10171/21678
Appears in Collections:DA - Medicina - Medicina Interna - Artículos de revista
DA - CIMA - Terapia génica y Hepatología - Inmunología hepatitis virales - Artículos de revista
DA - CIMA - Terapia génica y Hepatología - Inmunología experimental - Artículos de revista

Files in This Item:

There are no files associated with this item.

Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.